Abstract
Exosomes are important carriers of biological information that facilitate intercellular communication and participate in the pathophysiology of different cardiovascular diseases. Myocardial infarction is among the leading causes of death worldwide. Upon myocardial infarction, massive cardiomyocyte death triggers a strong inflammatory response which is a vital process of cardiac injury, repair, and remodeling. Increasing evidence has unveiled that exosomes are involved in the inflammatory response and immune regulation after myocardial infarction. In this review, we will summarize the biological function of exosomes in the pathophysiology of myocardial infarction, especially focusing on their roles in the modulation of inflammation and immune response after myocardial infarction which further influences myocardial repair and remodeling. We will also discuss the immunomodulation by exosomes derived from stem and progenitor cells in the treatment of myocardial infarction. A deep understanding of immunomodulation by exosomes may represent a promising therapeutic option for the treatment of myocardial infarction.
Similar content being viewed by others
References
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., et al. (2012). Executive summary: heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation, 125(1), 188–197.
Prabhu, S. D., & Frangogiannis, N. G. (2016). The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circulation Research, 119(1), 91–112.
Loyer, X., Vion, A. C., Tedgui, A., & Boulanger, C. M. (2014). Microvesicles as cell-cell messengers in cardiovascular diseases. Circulation Research, 114(2), 345–353.
Bei, Y., Das, S., Rodosthenous, R. S., Holvoet, P., Vanhaverbeke, M., Monteiro, M. C., et al. (2017). Extracellular vesicles in cardiovascular theranostics. Theranostics, 7(17), 4168–4182.
Zhang, H. G., & Grizzle, W. E. (2014). Exosomes: a novel pathway of local and distant intercellular communication that facilitates the growth and metastasis of neoplastic lesions. The American Journal of Pathology, 184(1), 28–41.
van der Pol, E., Boing, A. N., Harrison, P., Sturk, A., & Nieuwland, R. (2012). Classification, functions, and clinical relevance of extracellular vesicles. Pharmacological Reviews, 64(3), 676–705.
Kowal, J., Tkach, M., & Thery, C. (2014). Biogenesis and secretion of exosomes. Current Opinion in Cell Biology, 29, 116–125.
Zocco, D., Ferruzzi, P., Cappello, F., Kuo, W. P., & Fais, S. (2014). Extracellular vesicles as shuttles of tumor biomarkers and anti-tumor drugs. Frontiers in Oncology, 4, 267.
Qin, J., & Xu, Q. (2014). Functions and application of exosomes. Acta Poloniae Pharmaceutica, 71(4), 537–543.
Heijnen, H. F., Schiel, A. E., Fijnheer, R., Geuze, H. J., & Sixma, J. J. (1999). Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood, 94(11), 3791–3799.
Sarker, S., Scholz-Romero, K., Perez, A., Illanes, S. E., Mitchell, M. D., Rice, G. E., et al. (2014). Placenta-derived exosomes continuously increase in maternal circulation over the first trimester of pregnancy. Journal of Translational Medicine, 12, 204.
Beach, A., Zhang, H. G., Ratajczak, M. Z., & Kakar, S. S. (2014). Exosomes: an overview of biogenesis, composition and role in ovarian cancer. Journal of Ovarian Research, 7, 14.
Vicencio, J. M., Yellon, D. M., Sivaraman, V., Das, D., Boi-Doku, C., Arjun, S., et al. (2015). Plasma exosomes protect the myocardium from ischemia-reperfusion injury. Journal of the American College of Cardiology, 65(15), 1525–1536.
Bang, C., & Thum, T. (2012). Exosomes: new players in cell-cell communication. The International Journal of Biochemistry & Cell Biology, 44(11), 2060–2064.
Caby, M. P., Lankar, D., Vincendeau-Scherrer, C., Raposo, G., & Bonnerot, C. (2005). Exosomal-like vesicles are present in human blood plasma. International Immunology, 17(7), 879–887.
Bei, Y., Chen, T., Banciu, D. D., Cretoiu, D., & Xiao, J. (2017). Circulating exosomes in cardiovascular diseases. Advances in Experimental Medicine and Biology, 998, 255–269.
Mol, E. A., Goumans, M. J., & Sluijter, J. P. G. (2017). Cardiac progenitor-cell derived exosomes as cell-free therapeutic for cardiac repair. Advances in Experimental Medicine and Biology, 998, 207–219.
Frangogiannis, N. G. (2014). The inflammatory response in myocardial injury, repair, and remodelling. Nature Reviews. Cardiology, 11(5), 255–265.
Herskowitz, A., Choi, S., Ansari, A. A., & Wesselingh, S. (1995). Cytokine mRNA expression in postischemic/reperfused myocardium. The American Journal of Pathology, 146(2), 419–428.
Frangogiannis, N. G., Lindsey, M. L., Michael, L. H., Youker, K. A., Bressler, R. B., Mendoza, L. H., et al. (1998). Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation, 98(7), 699–710.
Chandrasekar, B., Smith, J. B., & Freeman, G. L. (2001). Ischemia-reperfusion of rat myocardium activates nuclear factor-KappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation, 103(18), 2296–2302.
Horckmans, M., Ring, L., Duchene, J., Santovito, D., Schloss, M. J., Drechsler, M., et al. (2017). Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. European Heart Journal, 38(3), 187–197.
Zouggari, Y., Ait-Oufella, H., Bonnin, P., Simon, T., Sage, A. P., Guerin, C., et al. (2013). B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nature Medicine, 19(10), 1273–1280.
Lambert, J. M., Lopez, E. F., & Lindsey, M. L. (2008). Macrophage roles following myocardial infarction. International Journal of Cardiology, 130(2), 147–158.
Troidl, C., Mollmann, H., Nef, H., Masseli, F., Voss, S., Szardien, S., et al. (2009). Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction. Journal of Cellular and Molecular Medicine, 13(9B), 3485–3496.
Shinde, A. V., & Frangogiannis, N. G. (2014). Fibroblasts in myocardial infarction: a role in inflammation and repair. Journal of Molecular and Cellular Cardiology, 70, 74–82.
Kain, V., Prabhu, S. D., & Halade, G. V. (2014). Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction. Basic Research in Cardiology, 109(6), 444.
Frangogiannis, N. G. (2012). Regulation of the inflammatory response in cardiac repair. Circulation Research, 110(1), 159–173.
Loyer, X., Zlatanova, I., Devue, C., Yin, M., Howangyin, K.-Y., Klaihmon, P., et al. (2018). Intra-cardiac release of extracellular vesicles shapes inflammation following myocardial infarction. Circulation Research, 123(1), 100–106.
Fujiu, K., Wang, J., & Nagai, R. (2014). Cardioprotective function of cardiac macrophages. Cardiovascular Research, 102(2), 232–239.
Frangogiannis, N. G. (2015). Emerging roles for macrophages in cardiac injury: cytoprotection, repair, and regeneration. The Journal of Clinical Investigation, 125(8), 2927–2930.
Wang, C., Zhang, C., Liu, L., A, X., Chen, B., Li, Y., et al. (2017). Macrophage-derived mir-155-containing exosomes suppress fibroblast proliferation and promote fibroblast inflammation during cardiac injury. Molecular Therapy, 25(1), 192–204.
Porrello, E. R., Mahmoud, A. I., Simpson, E., Johnson, B. A., Grinsfelder, D., Canseco, D., et al. (2013). Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. Proceedings of the National Academy of Sciences of the United States of America, 110(1), 187–192.
Porrello, E. R., Mahmoud, A. I., Simpson, E., Hill, J. A., Richardson, J. A., Olson, E. N., et al. (2011). Transient regenerative potential of the neonatal mouse heart. Science, 331(6020), 1078–1080.
Porrello, E. R., Johnson, B. A., Aurora, A. B., Simpson, E., Nam, Y. J., Matkovich, S. J., et al. (2011). MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes. Circulation Research, 109(6), 670–679.
Puente, B. N., Kimura, W., Muralidhar, S. A., Moon, J., Amatruda, J. F., Phelps, K. L., et al. (2014). The oxygen-rich postnatal environment induces cardiomyocyte cell-cycle arrest through DNA damage response. Cell, 157(3), 565–579.
Aurora, A. B., Porrello, E. R., Tan, W., Mahmoud, A. I., Hill, J. A., Bassel-Duby, R., et al. (2014). Macrophages are required for neonatal heart regeneration. The Journal of Clinical Investigation, 124(3), 1382–1392.
Gnecchi, M., He, H., Noiseux, N., Liang, O. D., Zhang, L., Morello, F., et al. (2006). Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. The FASEB Journal, 20(6), 661–669.
Uemura, R., Xu, M., Ahmad, N., & Ashraf, M. (2006). Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circulation Research, 98(11), 1414–1421.
Ni, J., Sun, Y., & Liu, Z. (2018). The potential of stem cells and stem cell-derived exosomes in treating cardiovascular diseases. Journal of Cardiovascular Translational Research.
Bagno, L., Hatzistergos, K. E., Balkan, W., & Hare, J. M. (2018). Mesenchymal stem cell-based therapy for cardiovascular disease: progress and challenges. Molecular Therapy, 26(7), 1610–1623.
Bian, S., Zhang, L., Duan, L., Wang, X., Min, Y., & Yu, H. (2014). Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. Journal of Molecular Medicine (Berlin), 92(4), 387–397.
Lai, R. C., Arslan, F., Lee, M. M., Sze, N. S., Choo, A., Chen, T. S., et al. (2010). Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Research, 4(3), 214–222.
Zhang, Z., Yang, J., Yan, W., Li, Y., Shen, Z., & Asahara, T. (2016). Pretreatment of cardiac stem cells with exosomes derived from mesenchymal stem cells enhances myocardial repair. Journal of the American Heart Association, 5(1).
Yu, B., Kim, H. W., Gong, M., Wang, J., Millard, R. W., Wang, Y., et al. (2015). Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection. International Journal of Cardiology, 182, 349–360.
Chen, L., Wang, Y., Pan, Y., Zhang, L., Shen, C., Qin, G., et al. (2013). Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury. Biochemical and Biophysical Research Communications, 431(3), 566–571.
Barile, L., Lionetti, V., Cervio, E., Matteucci, M., Gherghiceanu, M., Popescu, L. M., et al. (2014). Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovascular Research, 103(4), 530–541.
Arslan, F., Lai, R. C., Smeets, M. B., Akeroyd, L., Choo, A., Aguor, E. N. E., et al. (2013). Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Research, 10(3), 301–312.
Shao, L., Zhang, Y., Lan, B., Wang, J., Zhang, Z., Zhang, L., et al. (2017). MiRNA-sequence indicates that mesenchymal stem cells and exosomes have similar mechanism to enhance cardiac repair. BioMed Research International, 2017, 4150705.
Teng, X., Chen, L., Chen, W., Yang, J., Yang, Z., & Shen, Z. (2015). Mesenchymal stem cell-derived exosomes improve the microenvironment of infarcted myocardium contributing to angiogenesis and anti-inflammation. Cellular Physiology and Biochemistry, 37(6), 2415–2424.
Kim, J. H., Joo, H. J., Kim, M., Choi, S. C., Lee, J. I., Hong, S. J., et al. (2017). Transplantation of adipose-derived stem cell sheet attenuates adverse cardiac remodeling in acute myocardial infarction. Tissue Engineering. Part A, 23(1–2), 1–11.
Luo, Q., Guo, D., Liu, G., Chen, G., Hang, M., & Jin, M. (2017). Exosomes from MiR-126-overexpressing Adscs are therapeutic in relieving acute myocardial Ischaemic injury. Cellular Physiology and Biochemistry, 44(6), 2105–2116.
Liu, J., Jiang, M., Deng, S., Lu, J., Huang, H., Zhang, Y., et al. (2018). miR-93-5p-containing exosomes treatment attenuates acute myocardial infarction-induced myocardial damage. Molecular Therapy--Nucleic Acids, 11, 103–115.
Barile, L., Cervio, E., Lionetti, V., Milano, G., Ciullo, A., Biemmi, V., et al. (2018). Cardioprotection by cardiac progenitor cell-secreted exosomes: role of pregnancy-associated plasma protein-A. Cardiovascular Research, 114(7), 992–1005.
Santini, M. P., Lexow, J., Borsellino, G., Slonimski, E., Zarrinpashneh, E., Poggioli, T., et al. (2011). IGF-1Ea induces vessel formation after injury and mediates bone marrow and heart cross-talk through the expression of specific cytokines. Biochemical and Biophysical Research Communications, 410(2), 201–207.
de Couto, G., Gallet, R., Cambier, L., Jaghatspanyan, E., Makkar, N., Dawkins, J. F., et al. (2017). Exosomal microRNA transfer into macrophages mediates cellular postconditioning. Circulation, 136(2), 200–214.
Cambier, L., de Couto, G., Ibrahim, A., Echavez, A. K., Valle, J., Liu, W., et al. (2017). Y RNA fragment in extracellular vesicles confers cardioprotection via modulation of IL-10 expression and secretion. EMBO Molecular Medicine, 9(3), 337–352.
Gallet, R., Dawkins, J., Valle, J., Simsolo, E., de Couto, G., Middleton, R., et al. (2017). Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. European Heart Journal, 38(3), 201–211.
Cambier, L., Giani, J. F., Liu, W., Ijichi, T., Echavez, A. K., Valle, J., et al. (2018). Angiotensin II–induced end-organ damage in mice is attenuated by human exosomes and by an exosomal Y RNA fragment. Hypertension.
Grigorian-Shamagian, L., Liu, W., Fereydooni, S., Middleton, R. C., Valle, J., Cho, J. H., et al. (2017). Cardiac and systemic rejuvenation after cardiosphere-derived cell therapy in senescent rats. European Heart Journal, 38(39), 2957–2967.
Hulsmans, M., & Holvoet, P. (2013). MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovascular Research, 100(1), 7–18.
Huber, H. J., & Holvoet, P. (2015). Exosomes: emerging roles in communication between blood cells and vascular tissues during atherosclerosis. Current Opinion in Lipidology, 26(5), 412–419.
Raeven, P., Zipperle, J., & Drechsler, S. (2018). Extracellular vesicles as markers and mediators in Sepsis. Theranostics, 8(12), 3348–3365.
Real, J. M., Ferreira, L. R. P., Esteves, G. H., Koyama, F. C., Dias, M. V. S., Bezerra-Neto, J. E., et al. (2018). Exosomes from patients with septic shock convey miRNAs related to inflammation and cell cycle regulation: new signaling pathways in sepsis? Critical Care, 22, 68.
Wang, X., Gu, H., Qin, D., Yang, L., Huang, W., Essandoh, K., et al. (2015). Exosomal miR-223 contributes to mesenchymal stem cell-elicited cardioprotection in polymicrobial sepsis. Scientific Reports, 5, 13721.
Habertheuer, A., Korutla, L., Rostami, S., Reddy, S., Lal, P., Naji, A., et al. (2018). Donor tissue-specific exosome profiling enables noninvasive monitoring of acute rejection in mouse allogeneic heart transplantation. The Journal of Thoracic and Cardiovascular Surgery, 155(6), 2479–2489.
Kennel, P. J., Saha, A., Maldonado, D. A., Givens, R., Brunjes, D. L., Castillero, E., et al. (2018). Serum exosomal protein profiling for the non-invasive detection of cardiac allograft rejection. The Journal of Heart and Lung Transplantation, 37(3), 409–417.
Marino, J., Babiker-Mohamed, M. H., Crosby-Bertorini, P., Paster, J. T., LeGuern, C., Germana, S., et al. (2016). Donor exosomes rather than passenger leukocytes initiate alloreactive T cell responses after transplantation. Science Immunology, 1(1), aaf8759–aaf8759.
Liu, Q., Rojas-Canales, D. M., Divito, S. J., Shufesky, W. J., Stolz, D. B., Erdos, G., et al. (2016). Donor dendritic cell–derived exosomes promote allograft-targeting immune response. The Journal of Clinical Investigation, 126(8), 2805–2820.
Montecalvo, A., Shufesky, W. J., Beer Stolz, D., Sullivan, M. G., Wang, Z., Divito, S. J., et al. (2008). Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognition. Journal of Immunology, 180(5), 3081–3090.
Sukma Dewi, I., Celik, S., Karlsson, A., Hollander, Z., Lam, K., McManus, J.-W., et al. (2017). Exosomal miR-142-3p is increased during cardiac allograft rejection and augments vascular permeability through down-regulation of endothelial RAB11FIP2 expression. Cardiovascular Research, 113(5), 440–452.
Song, J., Huang, J., Chen, X., Teng, X., Song, Z., Xing, Y., et al. (2016). Donor-derived exosomes induce specific regulatory T cells to suppress immune inflammation in the allograft heart. [article]. Scientific Reports, 6, 20077.
Christia, P., & Frangogiannis, N. G. (2013). Targeting inflammatory pathways in myocardial infarction. European Journal of Clinical Investigation, 43(9), 986–995.
Giugliano, G. R., Giugliano, R. P., Gibson, C. M., & Kuntz, R. E. (2003). Meta-analysis of corticosteroid treatment in acute myocardial infarction. The American Journal of Cardiology, 91(9), 1055–1059.
Funding
This work was supported by the grants from National Natural Science Foundation of China (81770401 to Y.B.) and National Key Research and Development Program of China (2017YFC1700401 to Y.B.)
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Research Involving Human Participants and/or Animals
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed Consent
This article does not contain any studies with human participants.
Additional information
Associate Editor Enrique Lara-Pezzi oversaw the review of this article
Rights and permissions
About this article
Cite this article
Pan, W., Zhu, Y., Meng, X. et al. Immunomodulation by Exosomes in Myocardial Infarction. J. of Cardiovasc. Trans. Res. 12, 28–36 (2019). https://doi.org/10.1007/s12265-018-9836-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-018-9836-7